news
All
Company News
Press Releases
Scientific Announcements
Investment News
Feb 17, 2026 |
Press Releases
EpitogenX and Attomarker Sign Strategic Co-Development Agreement
Feb 10, 2026 |
Investment News
What an Acceleration Round means for Attomarker at this stage
May 29, 2024 |
Company News
Attomarker has been selected as one of the companies by Innovate UK
Nov 29, 2023 |
Investment News
Attomarker is Revolutionising Diagnostic Technology and the Potential of Big Data
Oct 12, 2020 |
Scientific Announcements
Were White House COVID victims lulled into false sense of security by current antigen tests?
Sep 8, 2020 |
Scientific Announcements
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Sep 7, 2020 |
Scientific Announcements
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Aug 10, 2020 |
Scientific Announcements
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Jul 8, 2020 |
Scientific Announcements
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Jun 16, 2020 |
Scientific Announcements
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Mar 24, 2020 |
Scientific Announcements
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Jan 15, 2020 |
Scientific Announcements
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
Nov 15, 2019 |
Scientific Announcements
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Nov 8, 2019 |
Scientific Announcements
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Sep 9, 2019 |
Scientific Announcements
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Sep 2, 2019 |
Scientific Announcements
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More
May 29, 2024 |
Company News
Attomarker has been selected as one of the companies by Innovate UK
Oct 12, 2020 |
Scientific Announcements
Were White House COVID victims lulled into false sense of security by current antigen tests?
Sep 8, 2020 |
Scientific Announcements
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Sep 7, 2020 |
Scientific Announcements
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Aug 10, 2020 |
Scientific Announcements
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Jul 8, 2020 |
Scientific Announcements
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Jun 16, 2020 |
Scientific Announcements
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Mar 24, 2020 |
Scientific Announcements
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Jan 15, 2020 |
Scientific Announcements
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
Nov 15, 2019 |
Scientific Announcements
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Nov 8, 2019 |
Scientific Announcements
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Sep 9, 2019 |
Scientific Announcements
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Sep 2, 2019 |
Scientific Announcements
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More
Feb 10, 2026 |
Investment News
What an Acceleration Round means for Attomarker at this stage
Nov 29, 2023 |
Investment News
Attomarker is Revolutionising Diagnostic Technology and the Potential of Big Data
Podcasts and Further Resources
Our series ‘Prof Talks’ dives into the science behind the Attomarker COVID Antibody Spectrum Test as well as covering topics such as ‘Hyper-immunity’ and ‘Children and Long COVID’.
We also run additional episodes with clinicians such as Dr Ben Sinclair covering the latest research in Long COVID recovery: turning the science into medicine.
Links to our video series and podcasts are available in the video carousel on this page (to the right on desktop and below on mobile or tablets), as well as on our YouTube channel here: Visit Attomarker’s YouTube Channel.
Professor Shaw and Attomarker also feature in other podcasts, programmes and articles, including: